Sort
130,381 grants matching “hiv”
Animal and Laboratory Core
$791,002Todd M Allen · Massachusetts General Hospital · P01 · FY2013 · AI
Transmissibility of GC and Ct Diagnosed using NAAT
$791,002Research Triangle Institute · R01 · FY2001 · HD
Novel strategies for eliminating HIV reservoirs in lymphoid tissues
$790,999Huanbin Xu · Tulane University Of Louisiana · R01 · FY2018 · DE
ZIMBABWE--COMMUNITY INTERVENTION TO REDUCE HIV/STD RISK
$790,918Battelle Centers/Pub Hlth Res &Evaluatn · U10 · FY2000 · MH
Genes, substance use, and HIV outcomes in people living with HIV across the US
$790,896Heidi M. Crane · University Of Washington · R01 · FY2020 · DA
Genes, substance use, and HIV outcomes in people living with HIV across the US
$790,896Heidi M. Crane · University Of Washington · R01 · FY2019 · DA
Towards point of care HIV detection using repurposed glucose meters
$790,884Suri Saranathan Iyer · Georgia State University · R33 · FY2022 · AI
Vaccination with invariant MHC-II-linked accessory antigens for protection from HIV infection
$790,880Ronald S. Veazey · Tulane University Of Louisiana · R01 · FY2020 · AI
Characterization of silently HBV-infected hepatocytes in HIV co-infection
$790,878Ashwin Balagopal · Johns Hopkins University · R01 · FY2020 · AI
Immune engineering of optimized sequential immunization strategies for HIV vaccines
$790,753Darrell J Irvine · Massachusetts Institute Of Technology · R61 · FY2021 · AI
Integrated analysis of CVD risk in HIV: gut microbiota, immune function and metabolites
$790,750Qibin Qi · Albert Einstein College Of Medicine · R01 · FY2020 · HL
HIV-Receptor Interactions and Related Anti-HIV Strategies
$790,730Edward Berger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
In vivo transformation of chimeric antigen receptor B cells for a functional cure of HIV
$790,719Michael R. Farzan · Boston Children'S Hospital · R01 · FY2023 · AI
Characterization of silently HBV-infected hepatocytes in HIV co-infection
$790,717Ashwin Balagopal · Johns Hopkins University · R01 · FY2018 · AI
Criminal Justice Drug Treatment Services Research Center
$790,652University Of Miami School Of Medicine · U01 · FY2005 · DA
Host Genetic Factors Associated with CNS Disease of HIV-Infected Children
$790,634Stephen A Spector · University Of California, San Diego · R01 · FY2011 · NS
Population genotyping of the germline immunoglobulin repertoire in AIDS-designated rhesus macaque breeding colonies
$790,624Steven Edward Bosinger · Emory University · R24 · FY2021 · AI
Cabotegravir PrEP: Actionable Robust Evidence for Translation into Practice (CABARET)
$790,624Julia L. Marcus · Harvard Pilgrim Health Care, Inc. · R01 · FY2024 · AI
Novel next-generation sequencing assay for monitoring multidrug resistant tuberculosis treatment in the setting of HIV infection
$790,569John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2018 · AI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC)
$790,559Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2018 · AI
Regulation of HIV latency by microglial-neuronal interactions
$790,503Jonathan Karn · Case Western Reserve University · R01 · FY2021 · DA
Imaging Brain Signal Transduction via Arachidonic and Docosahexaenoic Acids
$790,462Stanley I Rapoport · National Institute On Aging · ZIA · FY2013 · AG
Parental Involvement, Extra-Familial Contexts and Prevention of Drug Use Risk.
$790,442Daniel S Shaw · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DA
Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP
$790,427Christopher J Lyon · Tulane University Of Louisiana · R01 · FY2021 · HD
DAT 18-06 Feasibility and Acceptability of HIV, HCV, and Opioid Use Disorder Services in Syringe Service Programs
$790,403Bruce R Schackman · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DA